https://scholars.lib.ntu.edu.tw/handle/123456789/588094
標題: | Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia | 作者: | Chen, Chia-Hung Tu, Chih-Yen Chen, Wei-Chih Kuo, Li-Kuo Wang, Yao-Tung Fu, Pin-Kuei SHIH-CHI KU Fang, Wen-Feng Chen, Chin-Ming Lai, Chih-Cheng |
關鍵字: | cefoperazone-sulbactam; hospital-acquired pneumonia; piperacillin-tazobactam; ventilator-associated pneumonia;Cefoperazone-sulbactam; Hospital-acquired pneumonia; Piperacillin-tazobactam; Ventilator-associated pneumonia | 公開日期: | 2021 | 卷: | 14 | 來源出版物: | Infection and drug resistance | 摘要: | The aim of this study was to compare the usefulness of cefoperazone-sulbactam and that of piperacillin-tazobactam in the treatment of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/588094 | ISSN: | 1178-6973 | DOI: | 10.2147/IDR.S313828 | SDG/關鍵字: | brosym; cefoperazone plus sulbactam; piperacillin plus tazobactam; Acinetobacter; aged; APACHE; Article; Charlson Comorbidity Index; comorbidity; controlled study; demography; diarrhea; disease severity; drug efficacy; drug safety; female; hospital acquired pneumonia; human; international normalized ratio; Klebsiella pneumoniae; major clinical study; male; mortality rate; nonhuman; Pseudomonas aeruginosa; rash; retrospective study; Sequential Organ Failure Assessment Score; treatment outcome; ventilator associated pneumonia |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。